Thaleia Telidou, Ph.D
About Thaleia Telidou, Ph.D
Thaleia Telidou, Ph.D., is the Franchise Lead for Hematology at Bristol Myers Squibb in Greece, with extensive experience in pharmaceutical marketing and product management.
Current Role at Bristol Myers Squibb
Thaleia Telidou, Ph.D., currently holds the position of Franchise Lead, Hematology at Bristol Myers Squibb in Greece. In this role, she is responsible for overseeing the hematology franchise, driving strategic initiatives, and ensuring the successful management and development of hematologic products within the market.
Previous Positions at Bristol Myers Squibb
Before becoming Franchise Lead, Hematology, Thaleia Telidou worked as Senior Marketing Manager, Hematology at Bristol Myers Squibb from 2021 to 2023 for 2 years. In this position, she managed marketing operations for hematology products, contributing to the company's strategic objectives in Greece.
Experience at Lundbeck
Thaleia Telidou served as Regional Marketing Manager for Lundbeck's schizophrenia portfolio from 2017 to 2021 in Greece. Her responsibilities included managing marketing strategies across multiple countries such as Greece, Israel, Croatia, Slovenia, Romania, and Bulgaria. Her role required extensive regional coordination and strategic planning.
Career at Roche
Thaleia Telidou held several positions at Roche before her tenure at Lundbeck and Bristol Myers Squibb. She served as Brand Manager from 2012 to 2017 and as Product Specialist for both North and South Greece territories from 2006 to 2012. During her time at Roche, she gained valuable experience in product and brand management in the pharmaceutical sector.
Educational Background
Thaleia Telidou holds a Ph.D. in Chemistry from the University of Reading. Additionally, she earned an MSc in Chemistry from the Ethnikon kai Kapodistriakon Panepistimion Athinon and a B.Sc. in Chemistry from Aristotle University of Thessaloniki (AUTH). Her extensive educational background supports her expertise in the pharmaceutical industry.